STRO · ISSUER CIK 1382101
SUTRO BIOPHARMA, INC.
Between Aug 1, 2026 and Oct 29, 2026, 1 SUTRO BIOPHARMA, INC. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Sep 22, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 22, 202616:09 | Sep 18, 2026 | STRO | CHIEF SCIENTIFIC OFFICER | M · Exercise | — | +3,750 | 13,712 | +38% | — | ||
| Sep 22, 202616:09 | Sep 18, 2026 | STRO | CHIEF SCIENTIFIC OFFICER | F · Tax | $15.34 | −1,345 | 12,367 | -10% | $21K |